Case LawActs & SectionsOpen the app
IP Intelligence

Search Indian IP Case Law

Judgments of the Supreme Court and the High Courts on patents, trade marks, copyright, designs and geographical indications — organised by Act and section, each with a link to the judgment on the court’s website.

Clear filters

5 results

for “Pharmaceutical Patent”

Patents

E.R. Squibb and Sons, LLC & Ors. v. Zydus Lifesciences Limited

Delhi High Court · CS(COMM) 376/2024

In a quia timet action under Sections 48 and 108, a strong prima facie apprehension of imminent infringement, evidenced by the defendant's own regulatory and manufacturing conduct, can justify an interim injunction; and a biosimil…

BiotechnologyInterim InjunctionPatent InfringementPharmaceutical Patent
Patents

F. Hoffmann-La Roche AG & Anr. v. Natco Pharma Limited

Delhi High Court · FAO(OS)(COMM) 43/2025

A credible challenge to patent validity under Section 64(1)(f), showing that the claimed compound is an obvious and predictable structural modification of a compound already disclosed in the patentee's own earlier prior art, can d…

EvergreeningGenus-Species PatentInterim InjunctionInventive Step
Patents

F. Hoffmann-La Roche Ltd. & Anr. v. Cipla Ltd.

Delhi High Court · 2015 SCC OnLine Del 13619

A patent claim for a chemical compound is not to be narrowed to a specific polymorphic or crystalline form merely because the specification discusses particular polymorphs, where the claim itself is drafted broadly to cover the co…

Claim ConstructionPatent InfringementPharmaceutical PatentPolymorph
Patents

Novartis AG v. Union of India & Ors.

Supreme Court of India · (2013) 6 SCC 1

Section 3(d) of the Patents Act, 1970 imposes a distinct and higher threshold of patentability for new forms of known substances, over and above the ordinary tests of novelty and inventive step. A new form of a known substance mus…

EfficacyEvergreeningInventive StepKnown Substance
Patents

Vifor (International) Ltd. & Anr. v. MSN Laboratories Pvt. Ltd. & Anr.

Delhi High Court · FAO(OS)(COMM) 159/2023

A product-by-process claim protects the novel product itself where the product cannot otherwise be defined by its structural features, and obtainable by language in such a claim is descriptive rather than limiting; infringement is…

Claim ConstructionInterim InjunctionNoveltyPharmaceutical Patent